Welcome
Support Centre
30 August 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
A Randomised Trial of Conformal versus Conventional Radiotherapy in Pelvic Neoplasms
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN17264730
Date ISRCTN assigned19/08/2002
Local reference number(s)ICR/PELVIC
Public titleA Randomised Trial of Conformal versus Conventional Radiotherapy in Pelvic Neoplasms
Scientific title
AcronymN/A
Disease/condition/study domainCancer: Bladder (advanced), Bladder (superficial), Multiple Sites, Prostate, Rectum
Study hypothesisNot provided at time of registration
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Carcinoma of the pelvic region (eg prostate, bladder, rectum, etc)
2. Patients scheduled to undergo pelvic radiotherapy by a CT planned technique with less than four fields provided a satisfactory localisation on the simulator can be achieved
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date01/01/2001
Anticipated end date31/12/2001
Status of trialCompleted
Target number of participantsNot provided at time of registration
Interventions1. Group A: Conventional radiotherapy using a three field technique employing rectangular fields. Suggested dosage, 64 Gy in 2 Gy fractions five times a week
2. Group B: Conformal radiotherapy using a three field technique employing fields shaped with customised blocks drawn according to the beam's-eye view of the target volume. Suggested dosage, 64 Gy in 2 Gy fractions five times a week.
Primary outcome measure(s)Not provided at time of registration
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingInstitute of Cancer Research (UK)
Sponsor nameThe Institute of Cancer Research (UK)
Sponsor details123 Old Brompton Road
London
United Kingdom
SW7 3RP
Sponsor telephone+44(0) 20 7352 8133
Sponsor fax+44(0) 20 7370 5261
Sponsor emailsponsor@unknown.com
Sponsor websitehttp://www.icr.ac.uk
Contact nameDr - -
Contact detailsUKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
United Kingdom
NW1 2DA
Contact telephone+44 (0) 20 7670 4723
Contact fax+44 (0) 20 7670 4818
Contact emailregister@ctu.mrc.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN17264730
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central